Effect of Composition and Size on Surface Properties of Anti-Cancer Nanoparticles.
Doxil®
clinical translation
interfacial tension
liposomes
nanoparticles
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Aug 2023
30 Aug 2023
Historique:
received:
12
06
2023
revised:
09
08
2023
accepted:
11
08
2023
medline:
11
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
Liposomal formulations offer significant advantages as anticancer drug carriers for targeted drug delivery; however, due to their complexity, clinical translation has been challenging. In addition, liposomal product manufacturing has been interrupted in the past, as was the case for Doxil
Identifiants
pubmed: 37686222
pii: ijms241713417
doi: 10.3390/ijms241713417
pmc: PMC10487715
pii:
doi:
Substances chimiques
Liposomes
0
liposomal doxorubicin
0
Surface-Active Agents
0
Pulmonary Surfactants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIMHD NIH HHS
ID : U54 MD006882
Pays : United States
Organisme : NIMHD NIH HHS
ID : 2U54MD006882-06
Pays : United States
Références
J Oncol Pharm Pract. 2016 Aug;22(4):599-604
pubmed: 26183293
Mater Sci Eng C Mater Biol Appl. 2020 Dec;117:111270
pubmed: 32919634
ACS Biomater Sci Eng. 2020 Sep 14;6(9):4916-4928
pubmed: 33455287
Adv Exp Med Biol. 2018;1048:175-198
pubmed: 29453539
Adv Drug Deliv Rev. 2021 Sep;176:113851
pubmed: 34224787
Acc Chem Res. 2019 Sep 17;52(9):2445-2461
pubmed: 31424909
J Am Chem Soc. 2011 Mar 2;133(8):2525-34
pubmed: 21288025
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):28-51
pubmed: 26456916
Eur J Pharm Biopharm. 2019 Aug;141:70-80
pubmed: 31082511
Nanomedicine (Lond). 2016 Mar;11(6):673-92
pubmed: 27003448
Biotechnol Appl Biochem. 2015 Jul-Aug;62(4):547-55
pubmed: 25196743
Soft Matter. 2018 Dec 5;14(47):9599-9608
pubmed: 30457136
Int J Nanomedicine. 2020 Aug 06;15:5783-5802
pubmed: 32821101
Int J Nanomedicine. 2020 Jun 11;15:4091-4104
pubmed: 32606666
Eur Phys J E Soft Matter. 2017 May;40(5):53
pubmed: 28470433
Nanoscale. 2016 Apr 7;8(13):6948-57
pubmed: 26961355
Int J Pharm. 2021 Jan 5;592:120093
pubmed: 33212171
Int J Pharm. 2021 Aug 10;605:120807
pubmed: 34144133
J Control Release. 2023 Mar;355:760-778
pubmed: 36822241
J Control Release. 2012 Jun 10;160(2):117-34
pubmed: 22484195
Adv Drug Deliv Rev. 2020;154-155:102-122
pubmed: 32650041
Nanomedicine. 2019 Jun;18:146-156
pubmed: 30876818
Molecules. 2023 Jun 30;28(13):
pubmed: 37446806
Methods Enzymol. 2005;391:71-97
pubmed: 15721375
J Biomed Nanotechnol. 2020 Aug 1;16(8):1276-1295
pubmed: 33397557
J Pharm Pharm Sci. 2009;12(2):218-28
pubmed: 19732499
Pharmaceutics. 2023 Jul 09;15(7):
pubmed: 37514096
Bioeng Transl Med. 2021 Aug 13;6(3):e10246
pubmed: 34514159
Int J Mol Sci. 2022 Jul 05;23(13):
pubmed: 35806466
ACS Nano. 2022 Feb 22;16(2):2088-2100
pubmed: 35040637
Annu Rev Biomed Eng. 2012;14:1-16
pubmed: 22524388
Nanotheranostics. 2023 Mar 5;7(3):236-257
pubmed: 37064613
Cells. 2021 Jan 12;10(1):
pubmed: 33445454